Nader Pourmand is a Professor of Biomolecular Engineering leading the Biosensors and Bioelectrical Technology Group at the Baskin School of Engineering at the University of California Santa Cruz, Baskin School of Engineering. [1]
He has been published in Cancer Research, [2] PLoS ONE, [3] ACS, and the Proceedings of the National Academy of Sciences. [4]
Pourmand received his PhD at the Karolinska Institute, Stockholm, Sweden. [5] While he was at Stanford, his lab developed the science underlying Ion Torrent, a benchtop next-gen sequencing system (acquired by Life Technologies, then by Thermo Fisher). [6] He has been a cofounder of start-ups Pinpoint Science inc., [7] BioStinger Inc. (now part of Yokogawa, Japan), [5] [8] MagArray Inc., [9] [5] and contributed to others including Nvigen, [10] Ion Torrent, [6] Bioprobix, and Pathogenix. [11]
He has developed technology based on functionalized nanopipettes, which can be used to study genomics and proteomics of individual living cells at nanoscale. [12] [13] This nanopipette technology was described in Nature Nanotechnology as a major advance in Single cell genomics and was recognized by the NIH for the development of this technology for interrogating single living cells. [14] [15] This same nanopipette technology is the basis for Pinpoint Science Inc's handheld diagnostic platform for detecting microbial pathogens.
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)
Nader Pourmand is a Professor of Biomolecular Engineering leading the Biosensors and Bioelectrical Technology Group at the Baskin School of Engineering at the University of California Santa Cruz, Baskin School of Engineering. [1]
He has been published in Cancer Research, [2] PLoS ONE, [3] ACS, and the Proceedings of the National Academy of Sciences. [4]
Pourmand received his PhD at the Karolinska Institute, Stockholm, Sweden. [5] While he was at Stanford, his lab developed the science underlying Ion Torrent, a benchtop next-gen sequencing system (acquired by Life Technologies, then by Thermo Fisher). [6] He has been a cofounder of start-ups Pinpoint Science inc., [7] BioStinger Inc. (now part of Yokogawa, Japan), [5] [8] MagArray Inc., [9] [5] and contributed to others including Nvigen, [10] Ion Torrent, [6] Bioprobix, and Pathogenix. [11]
He has developed technology based on functionalized nanopipettes, which can be used to study genomics and proteomics of individual living cells at nanoscale. [12] [13] This nanopipette technology was described in Nature Nanotechnology as a major advance in Single cell genomics and was recognized by the NIH for the development of this technology for interrogating single living cells. [14] [15] This same nanopipette technology is the basis for Pinpoint Science Inc's handheld diagnostic platform for detecting microbial pathogens.
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)